Lifecore Biomedical, Inc. LFCR
6.42 USD +0.03 (+0.47%)
At closeNov 3, 2026, 4:01 PM EST
6.42 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
6.41 Day range 6.44
3.66 52-week range 8.82
- YTD
- -21.52%
- 1 year
- -9.70%
Analyst view
Price target (mean) 8.00 +24.6% upside
Now 6.42
- Target (low)
- 6.00
- Target (mean)
- 8.00
- Target (high)
- 10.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.305 | -0.34 – -0.27 | -0.0682 | -347.2% | 29.75M | -1.3% | 2 |
| Next quarter | -0.155 | -0.16 – -0.15 | 0.425 | -136.5% | 34.74M | -2.7% | 2 |
| Current year | -0.985 | -1.03 – -0.94 | -0.322 | -205.9% | 128.55M | +0.2% | 2 |
| Next year | -0.715 | -0.83 – -0.60 | -0.985 | +27.4% | 139.35M | +8.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Sep 5, 2024 | Craig-Hallum | Initiated | — | Buy |
| Aug 28, 2024 | Barrington Research | Downgrade | Outperform | Market Perform |
| Sep 1, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 1, 2023 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Jun 2, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| May 24, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 21, 2023 | Barrington Research | Maintained | — | Outperform |
| Mar 20, 2023 | Barrington Research | Maintained | — | Outperform |
| Mar 20, 2023 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Mar 17, 2023 | Stephens & Co. | Reiterated | — | Overweight |